Terms: = Pancreatic cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
18 results:
1. Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
Cowzer D; Shah RH; Chou JF; Kundra R; Punn S; Fiedler L; DeMore A; Capanu M; Berger MF; Reidy-Lagunes D; Raj N
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38252063
[TBL] [Abstract] [Full Text] [Related]
2.
Mulkidjan RS; Saitova ES; Preobrazhenskaya EV; Asadulaeva KA; Bubnov MG; Otradnova EA; Terina DM; Shulga SS; Martynenko DE; Semina MV; Belogubova EV; Tiurin VI; Amankwah PS; Martianov AS; Imyanitov EN
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686416
[TBL] [Abstract] [Full Text] [Related]
3. A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract] [Full Text] [Related]
4. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/trkc signaling pathway.
Xu X; Lu X; Chen L; Peng K; Ji F
J Clin Lab Anal; 2022 Nov; 36(11):e24719. PubMed ID: 36181286
[TBL] [Abstract] [Full Text] [Related]
6. Molecular characterisation of pancreatic ductal adenocarcinoma with
Allen MJ; Zhang A; Bavi P; Kim JC; Jang GH; Kelly D; Perera S; Denroche RE; Notta F; Wilson JM; Dodd A; Ramotar S; Hutchinson S; Fischer SE; Grant RC; Gallinger S; Knox JJ; O'Kane GM
J Clin Pathol; 2023 Mar; 76(3):158-165. PubMed ID: 34583947
[TBL] [Abstract] [Full Text] [Related]
7. Early-Onset Pancreas cancer: Clinical Descriptors, Genomics, and Outcomes.
Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
[TBL] [Abstract] [Full Text] [Related]
8. High Detection Rates of pancreatic cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9.
Majumder S; Taylor WR; Foote PH; Berger CK; Wu CW; Mahoney DW; Bamlet WR; Burger KN; Postier N; de la Fuente J; Doering KA; Lidgard GP; Allawi HT; Petersen GM; Chari ST; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 May; 27(9):2523-2532. PubMed ID: 33593879
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer.
Chen Z; Huang Z; Luo Y; Zou Q; Bai L; Tang G; Wang X; Cao G; Huang M; Xiang J; Yu H
J Transl Med; 2021 Feb; 19(1):73. PubMed ID: 33593392
[TBL] [Abstract] [Full Text] [Related]
10. Accurate and efficient detection of gene fusions from RNA sequencing data.
Uhrig S; Ellermann J; Walther T; Burkhardt P; Fröhlich M; Hutter B; Toprak UH; Neumann O; Stenzinger A; Scholl C; Fröhling S; Brors B
Genome Res; 2021 Mar; 31(3):448-460. PubMed ID: 33441414
[TBL] [Abstract] [Full Text] [Related]
11. Salivary Gland cancer in the Era of Routine Next-Generation Sequencing.
Todorovic E; Dickson BC; Weinreb I
Head Neck Pathol; 2020 Jun; 14(2):311-320. PubMed ID: 32124419
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
[TBL] [Abstract] [Full Text] [Related]
13. MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer.
Liu D; Song L; Dai Z; Guan H; Kang H; Zhang Y; Yan W; Zhao X; Zhang S
Biochem Biophys Res Commun; 2018 Nov; 505(4):1077-1083. PubMed ID: 30314698
[TBL] [Abstract] [Full Text] [Related]
14. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
Deihimi S; Lev A; Slifker M; Shagisultanova E; Xu Q; Jung K; Vijayvergia N; Ross EA; Xiu J; Swensen J; Gatalica Z; Andrake M; Dunbrack RL; El-Deiry WS
Oncotarget; 2017 Jun; 8(25):39945-39962. PubMed ID: 28591715
[TBL] [Abstract] [Full Text] [Related]
15. Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
Kubo T; Kuroda Y; Kokubu A; Hosoda F; Arai Y; Hiraoka N; Hirohashi S; Shibata T
Pancreas; 2009 Oct; 38(7):e200-6. PubMed ID: 19893451
[TBL] [Abstract] [Full Text] [Related]
16. Somatic mutations of GUCY2F, EPHA3, and ntrk3 in human cancers.
Wood LD; Calhoun ES; Silliman N; Ptak J; Szabo S; Powell SM; Riggins GJ; Wang TL; Yan H; Gazdar A; Kern SE; Pennacchio L; Kinzler KW; Vogelstein B; Velculescu VE
Hum Mutat; 2006 Oct; 27(10):1060-1. PubMed ID: 16941478
[TBL] [Abstract] [Full Text] [Related]
17. Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer.
Schneider MB; Standop J; Ulrich A; Wittel U; Friess H; Andrén-Sandberg A; Pour PM
J Histochem Cytochem; 2001 Oct; 49(10):1205-10. PubMed ID: 11561004
[TBL] [Abstract] [Full Text] [Related]
18. Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma.
Sakamoto Y; Kitajima Y; Edakuni G; Sasatomi E; Mori M; Kitahara K; Miyazaki K
Oncol Rep; 2001; 8(3):477-84. PubMed ID: 11295066
[TBL] [Abstract] [Full Text] [Related]
